TNNT3 polyclonal antibody, Unconjugated, Rabbit

Catalog Number: BWT-BS76251
Article Name: TNNT3 polyclonal antibody, Unconjugated, Rabbit
Biozol Catalog Number: BWT-BS76251
Supplier Catalog Number: BS76251
Alternative Catalog Number: BWT-BS76251-50UL,BWT-BS76251-100UL
Manufacturer: Bioworld Technology
Host: Rabbit
Category: Antikörper
Application: WB
Species Reactivity: Mouse, Rat
Immunogen: Recombinant fusion protein of human TNNT3(NP_001036246.1).
Conjugation: Unconjugated
Alternative Names: TNNT3,TNTF,troponin T3
The binding of Ca(2+) to the trimeric troponin complex initiates the process of muscle contraction. Increased Ca(2+) concentrations produce a conformational change in the troponin complex that is transmitted to tropomyosin dimers situated along actin filaments. The altered conformation permits increased interaction between a myosin head and an actin filament which, ultimately, produces a muscle contraction. The troponin complex has protein subunits C, I, and T. Subunit C binds Ca(2+) and subunit I binds to actin and inhibits actin-myosin interaction. Subunit T binds the troponin complex to the tropomyosin complex and is also required for Ca(2+)-mediated activation of actomyosin ATPase activity. There are 3 different troponin T genes that encode tissue-specific isoforms of subunit T for fast skeletal-, slow skeletal-, and cardiac-muscle. This gene encodes fast skeletal troponin T protein, also known as troponin T type 3. Alternative splicing results in multiple transcript variants encoding additional distinct troponin T type 3 isoforms. A developmentally regulated switch between fetal/neonatal and adult troponin T type 3 isoforms occurs. Additional splice variants have been described but their biological validity has not been established. Mutations in this gene may cause distal arthrogryposis multiplex congenita type 2B (DA2B).
Molecular Weight: 37kDa
UniProt: P45378
Purity: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Form: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Application Dilute: WB,1:200 - 1:2000
Application Notes: Unmodification